[1]陈毅,张兆辉,蔡志友.血压与阿尔茨海默病[J].卒中与神经疾病杂志,2017,24(04):275-281+296.[doi:10.3969/j.issn.1007-0478.2017.04.001]
点击复制

血压与阿尔茨海默病()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第24卷
期数:
2017年04期
页码:
275-281+296
栏目:
述 评
出版日期:
2017-08-26

文章信息/Info

文章编号:
1007-0478(2017)04-0275-08
作者:
陈毅张兆辉蔡志友
442000 十堰市,湖北医药学院附属人民医院 十堰市人民医院神经内科[陈毅 蔡志友(通信作者)]; 武汉大学人民医院神经内科(张兆辉)
分类号:
R749 R742
DOI:
10.3969/j.issn.1007-0478.2017.04.001

参考文献/References:

[1] Feldstein CA.Association between chronic blood pressure changes and development of Alzheimer's disease[J].J Alzheimers Dis,2012,32(3):753-763.
[2] Guo Z,Viitanen M,Fratiglioni L,et al.Low blood pressure and dementia in elderly People: the Kungsholmen project[J].BMJ,1996,312(734):805-808.
[3] Landin K,Blennow K,Wallin A,et al.Low blood pressure and blood glucose levels in Alzheimer's disease[J].Evidence for a hypometabolic disorder?J Intern Med,1993,233(4):357-363.
[4] Qiu C,Von Strauss E,Fastbom J,et al.Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study[J].Arch Neurol,2003,60(2):223-228.
[5] Verghese J,Lipton RB,Hall CB,et al.Low blood pressure and the risk of dementia in very old individuals[J].Neurology,2003,61(12):1667-1672.
[6] Power MC,Weuve J,Gagne JJ,et al.The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis[J].Epidemiology,2011,22(5):646-659.
[7] Morris MC,Scherr PA,Hebert LE,et al.Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study[J].Arch Neurol,2001,58(10):1640-1646.
[8] Guo Z,Viitanen M,Fratiglioni L,et al.Low blood pressure and early death of elderly People with dementia[J].Lancet,1998,352(9133):1035-1036.
[9] Mckhann G,Drachman D,Folstein M,et al.Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease[J].Neurology,1984,34(7):939-944.
[10] Siennicki-Lantz A,Lilja B,Elmst hl S.Orthostatic hypotension in Alzheimer's disease: result or cause of brain dysfunction?[J].Aging(Milano),1999,11(3):155-160.
[11] Allan LM,Ballard CG,Allen J,et al.Autonomic dysfunction in dementia[J].J Neurol Neurosurg Psychiatry,2007,78(7):671-677.
[12] Allan LM, Ballard CG, Rowan EN, et al. Incidence and prediction of falls in dementia: a prospective study in older people[J]. PLoS One, 2009, 4(5):e5521.
[13] Freidenberg DL,Shaffer LE,Macalester S,et al.Orthostatic hypotension in patients with dementia: clinical features and response to treatment[J].Cogn Behav Neurol,2013,26(3):105-120.
[14] Vitiello B,Veith RC,Molchan SE,et al.Autonomic dysfunction in patients with dementia of the Alzheimer type[J].Biol Psychiatry,1993,34(7):428-433.
[15] Zakrzewska-Pniewska B, Gawel M, Szmidt-Salkowska E, et al. Clinical and functional assessment of dysautonomia and its correlation in Alzheimer's disease[J]. Am J Alzheimers Dis Other Demen 2012, 27(8):592-599.
[16] Jensen-Dahm C,Waldemar G,Staehelin Jensen T,et al.Autonomic dysfunction in patients with mild to moderate alzheimer's disease[J].J Alzheimers Dis,2015,47(3):681-689.
[17] Femminella GD,Rengo G,Komici K,et al.Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature[J].J Alzheimers Dis,2014,42(2):369-377.
[18] Elmst hl S,Petersson M,Lilja B,et al.Autonomic cardiovascular responses to tilting in patients with Alzheimer's disease and in healthy elderly women[J].Age Ageing,1992,21(4):301-307.
[19] Jensen-Dahm C,Waldemar G,Jensen T,et al.Autonomic dysfunction in Alzheimer's disease[J].European Journal of Neurology,2015,22(1, SI):223.
[20] Fong SS, Navarrete CD, Perfecto SE, et al. Behavioral and autonomic reactivity to moral dilemmas in frontotemporal dementia versus Alzheimer's disease[Z]. Soc Neurosci, 2016:1-10.
[21] Kuperstein F,Brand A,Yavin E.Amyloid abeta1-40 preconditions non-apoptotic signals in vivo and protects fetal rat brain from intrauterine ischemic stress[J].J Neurochem,2004,91(4):965-974.
[22] Shah NS,Vidal JS,Masaki K,et al.Plasma beta-amyloid,and the risk for alzheimer disease:the Honolulu Asia aging study[J].Hypertension,2012,59(4):780-786.
[23] Purnell C,Gao S,Callahan CM,et al.Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature[J].Alzheimer Dis Assoc Disord,2009,23(1):1-10.
[24] Snowdon DA,Nun Study.Healthy aging and dementia: findings from the Nun Study[J].Ann Intern Med,2003,139(5 Pt 2):450-454.
[25] Knopman DS,Roberts R.Vascular risk factors: imaging and neuropathologic correlates[J].J Alzheimers Dis,2010,20(3):699-709.
[26] Barnes DE,Yaffe K.The projected effect of risk factor reduction on Alzheimer's disease prevalence[J].The Lancet Neurology,2011,10(9):819-828.
[27] Launer LJ,Ross GW,Petrovitch H,et al.Midlife blood pressure and dementia: the Honolulu-Asia aging study[J].Neurobiol Aging,2000,21(1):49-55.
[28] Launer LJ,Hughes T,Yu B,et al.Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study[J].Hypertension,2010,55(6):1352-1359.
[29] Kivipelto M,Helkala EL,Laakso MP,et al.Midlife vascular risk factors and Alzheimer's disease in later Life: longitudinal, population based study[J].BMJ,2001,322(730):1447-1451.
[30] Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease[J]. Arch Neurol, 2005, 62(10):1556-1560.
[31] Wu C,Zhou D,Wen C,et al.Relationship between blood pressure and Alzheimer's disease in Linxian County, China[J].Life Sci,2003,72(10):1125-1133.
[32] Ninomiya T, Ohara T, Hirakawa Y, et al. Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study[J]. Hypertension, 2011, 58(1):22-28.
[33] Yang YH,Roe CM,Morris JC.Relationship between late-life hypertension, blood pressure, and Alzheimer's disease[J].Am J Alzheimers Dis Other Demen,2011,26(6):457-462.
[34] Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study[J]. Neurobiol Aging, 2000, 21(1):57-62.
[35] Stewart R,Xue QL,Masaki K,et al.Change in blood pressure and incident dementia: a 32-year prospective study[J].Hypertension,2009,54(2):233-240.
[36] Korf ES,White LR,Scheltens P,et al.Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study[J].Hypertension,2004,44(1):29-34.
[37] Joas E,B ckman K,Gustafson D,et al.Blood pressure trajectories from midlife to late Life in relation to dementia in women followed for 37 years[J].Hypertension,2012,59(4):796-801.
[38] Posner HB,Tang MX,Luchsinger J,et al.The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function[J].Neurology,2002,58(8):1175-1181.
[39] Qiu C,Winblad B,Viitanen M,et al.Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study[J].Stroke,2003,34(3):594-599.
[40] Luchsinger JA,Reitz C,Honig LS,et al.Aggregation of vascular risk factors and risk of incident Alzheimer disease[J].Neurology,2005,65(4):545-551.
[41] Li G,Rhew IC,Shofer JB,et al.Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study[J].J Am Geriatr Soc,2007,55(8):1161-1167.
[42] Qiu C.Epidemiological findings of vascular risk factors in Alzheimer's disease: implications for therapeutic and preventive intervention[J].Expert Rev Neurother,2011,11(11):1593-1607.
[43] Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension[J]. Circulation, 1976, 53(4):720-727.
[44] Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction[J]. Cell Metab, 2008, 7(6):476-484.
[45] Vasilevko V, Passos GF, Quiring D,et al. Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Ann N Y Acad Sci, 2010, 12(7):58-70.
[46] Capone C,Faraco G,Park L,et al.The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension[J].Am J Physiol Heart Circ Physiol,2011,300(1):H397-H407.
[47] Matsushita K,Kuriyama Y,Nagatsuka K,et al.Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients[J].Hypertension,1994,23(5):565-568.
[48] Immink RV.Van den born BJ,van montfrans GA,koopmans RP,karemaker JM,van lieshout JJ:impaired cerebral autoregulation in patients with malignant hypertension[J].Circulation,2004,110(15):2241-2245.
[49] Hainsworth AH,Markus HS.Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review[J].J Cereb Blood Flow Metab,2008,28(12):1877-1891.
[50] Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study[J]. Stroke, 1996, 27(12):2262-2270.
[51] Kalaria RN.Cerebral vessels in ageing and Alzheimer's disease[J].Pharmacol Ther,1996,72(3):193-214.
[52] Cai Z,Wang C,He W,et al.Cerebral small vessel disease and Alzheimer's disease[J].Clin Interv Aging,2015,10(10):1695-1704.
[53] Thore CR,Anstrom JA,Moody DM,et al.Morphometric analysis of arteriolar tortuosity in human cerebral white matter of preterm, young, and aged subjects[J].J Neuropathol Exp Neurol,2007,66(5):337-345.
[54] Baumbach GL,Heistad DD,Siems JE.Effect of sympathetic nerves on composition and distensibility of cerebral arterioles in rats[J].J Physiol,1989,416(1):123-140.
[55] De La Torre JC.Mussivand T[J].Can disturbed brain microcirculation cause Alzheimer's disease?Neurol Res,1993,15(3):146-153.
[56] Launer LJ,Petrovitch H,Ross GW,et al.AD brain pathology: vascular origins? Results from the HAAS autopsy study[J].Neurobiol Aging,2008,29(10):1587-1590.
[57] De La Torre JC.Pathophysiology of neuronal energy crisis in Alzheimer's disease[J].Neurodegener Dis,2008,5(3/4):126-132.
[58] Mawuenyega KG,Sigurdson W,Ovod V,et al.Decreased clearance of CNS beta-Amyloid in alzheimer's disease[J].Science,2010,330(612):1774.
[59] Maalikjy Akkawi N,Borroni B,Agosti C,et al.Volume reduction in cerebral blood flow in patients with Alzheimer's disease: a sonographic study[J].Dement Geriatr Cogn Disord,2003,16(3):163-169.
[60] Ruitenberg A,Den Heijer T,Bakker SL,et al.Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study[J].Ann Neurol,2005,57(6):789-794.
[61] Sparks DL,Scheff SW,Liu H,et al.Increased incidence of neurofibrillary tangles(NFT)in non-demented individuals with hypertension[J].J Neurol Sci,1995,131(2):162-169.
[62] Tian N,Moore RS,Braddy S,et al.Interactions between oxidative stress and inflammation in salt-sensitive hypertension[J].Am J Physiol Heart Circ Physiol,2007,293(6):H3388-H3395.
[63] Van Exel E,Eikelenboom P,Comijs H,et al.Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease[J].Arch Gen Psychiatry,2009,66(11):1263-1270.
[64] Staessen JA,Richart T,Birkenh ger WH.Less atherosclerosis and lower blood pressure for a meaningful Life perspective with more brain[J].Hypertension,2007,49(3):389-400.
[65] Thaisetthawatkul P,Boeve BF,Benarroch EE,et al.Autonomic dysfunction in dementia with Lewy bodies[J].Neurology,2004,62(10):1804-1809.
[66] Kennelly SP,Lawlor BA,Kenny RA.Blood pressure and the risk for dementia-A double edged sword[J].Ageing Res Rev,2009,8(2):61-70.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金项目(编号为81070878/H0902和81671051/H0902),湖北省自然科学基金项目(编号为2015CFB260)、湖北省卫计委基金项目(编号为WJ2015MB219)和十堰市自然科学基金项目(编号为15K70)
更新日期/Last Update: 2017-08-20